Genetics

This blog post examines the study “Metabolome-based signature of disease pathology in MS,” which explores how changes in circulating metabolites may provide new insights into the diagnosis and biological mechanisms of multiple sclerosis. Using targeted and untargeted metabolomics combined with gene-expression and genetic analyses, the researchers identified six metabolites associated with MS, including pyroglutamate, laurate, acylcarnitine C14:1, N-methylmaleimide, and two phosphatidylcholines. The findings connect these metabolic alterations with oxidative stress, lipid metabolism, mitochondrial dysfunction, apoptosis, immune regulation, and genetic susceptibility, highlighting the potential of blood-based metabolic signatures as future biomarkers and therapeutic targets while emphasizing the need for validation in larger and more diverse patient populations.